About this trial
Through a pilot randomized controlled trial (RCT), we aim to test the feasibility and preliminary impact of two online educational resources among adult patients with thyroid cancer. Each online program can be accessed on the patient's personal device, and will be provided to the patient following a diagnosis of thyroid cancer but before meeting with their surgeon to discuss treatment options. The goal of the resource is to educate patients on the various treatment options for thyroid cancer prior to surgical consultation, so that clinic visit time can be better utilized to discuss patient questions and priorities, and support shared decision making. Clinical (TC-MAX; thyroid cancer related anxiety) and behavioral outcomes (decisional conflict, shared-decision making, treatment decision) will be assessed via online surveys 1-day and 14-days post-visit.
Eligibility criteria
Qualifiers
≤2cm Bethesda 6 thyroid nodule (papillary thyroid carcinoma) (T1N0)
≤2cm Bethesda 5 thyroid nodule
≤2cm Bethesda 3-4 thyroid nodule with molecular testing that confers >75% risk of malignancy
Able to understand and complete questionnaires independently in English
Disqualifiers
Cognitive impairment or other condition that, in the opinion of the investigators, would interfere with protocol participation
Has nodule >2cm in size, or with non-papillary thyroid carcinoma histology
High-grade or poorly differentiated papillary thyroid carcinoma (PTC) variants
Central or lateral neck lymphadenopathy suspicious for PTC
Trial design
Treatments tested in this trial
- THRIVE
- ACS "After a Thyroid Cancer Diagnosis" Flyer